wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q50050377-4DE169B3-2692-48AA-8981-BA9F7967AA1C
Q50050377-4DE169B3-2692-48AA-8981-BA9F7967AA1C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50050377-4DE169B3-2692-48AA-8981-BA9F7967AA1C
Nimotuzumab combined with gemcitabine and cisplatin as second-line chemotherapy for advanced non-small-cell lung cancer.
P2860
Q50050377-4DE169B3-2692-48AA-8981-BA9F7967AA1C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50050377-4DE169B3-2692-48AA-8981-BA9F7967AA1C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
529f9f7952ccffc1a2c2c6e157a5ae502ee91d44
P2860
A benefit-risk assessment of erlotinib in non-small-cell lung cancer and pancreatic cancer.